Acesis Biomed Appoints Dr. Frederic Fasano to Board of Directors
Acesis Biomed, a preclinical stage biotechnology company, has announced the appointment of Dr. Frederic Fasano to its Board of Directors. Dr. Fasano brings a wealth of experience in the pharmaceutical and biotech industry, with over 30 years of international leadership experience. He has a proven track record in delivering strategic growth and value in various companies, including publicly traded and private entities. His expertise in corporate development, operational scaling, and capital markets will be invaluable to Acesis Biomed as it develops its innovative pipeline for men's health conditions associated with low testosterone.
Key Takeaways:
- Dr. Frederic Fasano, a veteran pharmaceutical and biotech executive, has been appointed to the Board of Directors of Acesis Biomed.
- Dr. Fasano has over 30 years of international leadership experience, with a proven track record in delivering strategic growth and value in various companies.
- He currently serves as Chief Strategy & Corporate Development Officer at MaaT Pharma, a clinical-stage biotech company.
- Dr. Fasano is also the Founder and Chairman of Alpioner Therapeutics, a preclinical-stage biotech company developing a proprietary vaccine platform.
- He has held board roles in various organizations, including as a Director at ILKOS Therapeutics and Chair of the Board at Innovative Medicines Canada.
- Dr. Fasano holds a Doctor of Pharmacy degree from Universite Paris-Saclay, a Master Degree in Business Administration from ESSEC Business School (France), and the Certified Corporate Director (ICD.D) designation from McGill University.
Statistics:
- 30 years: Dr. Fasano's experience in the pharmaceutical and biotech industry.
- 5: Number of companies where Dr. Fasano has served as a board member or higher.
- 2: Number of preclinical-stage biotech companies that Dr. Fasano is associated with, including Acesis Biomed and Alpioner Therapeutics.
- 3: Number of degrees held by Dr. Fasano, including a Doctor of Pharmacy degree and a Master Degree in Business Administration.
Sources:
- Acesis Biomed press release, September 09, 2025.
- MaaT Pharma website.
- Alpioner Therapeutics website.